PROFESSIONAL EDITION

The largest community of pharma leaders

Industry News

      Personal Genome Diagnostics and Mayo Clinic Enter Strategic Collaboration to Enhance Patient Care in Oncology

      BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of...

      ERS Genomics Announces Agreement With New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents

      DUBLIN & IPSWICH, Mass.--(BUSINESS WIRE)--ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr....

      Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride in Retinal Degeneration Treatment

      SEATTLE--(BUSINESS WIRE)--Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of...

      Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy  

      NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its previously announced divestment of its oral solid, biologics, and sterile product...

      Rubicon Research Acquires Impopharma Canada

      MUMBAI, India--(BUSINESS WIRE)--As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited, a leading specialty pharmaceutical company, today...

      Recent Articles